Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands

European Journal of Medicinal Chemistry

Volumn 45, Issue 4, 2010, Pages 1508-1514

  Weber, Karen C ^a   Salum, Lívia B ^b   Honório, Káthia M ^b,c   Andricopulo, Adriano D ^b   da Silva, Albérico B F ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

3D QSAR; CoMFA; Drug design; Galahad; Pharmacophore

Indexed keywords

SEROTONIN 1 ANTAGONIST;

ARTICLE; BINDING AFFINITY; LIGAND BINDING; PHARMACOPHORE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING; STATISTICAL MODEL;

EID: 77649189967     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.12.059     Document Type: Article

References (37)

1. Pierce K.L., Premont R.T., and Lefkowitz R.J. Nat. Rev. Mol. Cell Biol. 3 (2002) 639-650
2. Hoyer D., Hannon J.P., and Martin G.R. Pharmacol., Biochem. Behav. 71 (2002) 533-554
3. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., and Hen R. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14476-14481
4. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., and Tecott L.H. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15049-15054
5. Pucadyil T.J., Kalipatnapu S., and Chattopadhyay A. Cell. Mol. Neurobiol. 25 (2005) 553-580
6. Lopez-Rodriguez M.L., Ayala D., Benhamu B., Morcillo M.J., and Viso A. Curr. Med. Chem. 9 (2002) 443-469
7. Gaillard P., Carrupt P.A., Testa B., and Schambel P. J. Med. Chem. 39 (1996) 126-134
8. Menziani M.C., de Benedetti P.G., and Karelson M. Bioorg. Med. Chem. 6 (1998) 535-550
9. López-Rodríguez M.L., Morcillo M.J., Fernández E., Rosado M.L., Pardo L., and Schaper K.J. J. Med. Chem. 44 (2001) 198-207
10. Weber K.C., and Da Silva A.B.F. Eur. J. Med. Chem. 43 (2008) 364-372
11. Weber K.C., Honorio K.M., Andricopulo A.D., and Da Silva A.B.F. Med. Chem. 4 (2008) 328-335
12. Oficialdegui A.M., Martinez J., Pérez S., Heras B., Irurzun M., Palop J.A., Tordera R., Lasheras B., Del Rio J., and Monge A. Farmaco 55 (2000) 345-353
13. Martínez-Esparza J., Pérez-Silanes S., Oficialdegui A.M., Heras B., Orús L., Villanueva H., Palop J.A., Roca J., Mourelle M., Bosch A., Del Castillo J.C., Lasheras B., Tordera R., Del Rio J., and Monge A. Eur. J. Med. Chem. 36 (2001) 55-61
14. Martínez-Esparza J., Oficialdegui A.M., Pérez-Silanes S., Heras B.B., Orús L., Palop J.A., Lasheras B., Roca J., Mourelle M., Bosch A., Del Castillo J.C., Tordera R., Del Rio J., and Monge A. J. Med. Chem. 44 (2001) 418-428
15. Orús L., Pérez-Silanes S., Oficialdegui A.M., Martínez-Esparza J., Del Castillo J.C., Mourelle M., Langer T., Guccione S., Donzella G., Krovat E.M., Poptodorov K., Lasheras B., Ballaz S., Hervíaz I., Tordera R., Del Rio J., and Monge A. J. Med. Chem. 45 (2002) 4128-4139
16. Blier P., de Montigny C., and Chaput Y. J. Clin. Psychiatry 51 (1990) 14-20
17. Sharp T., Umbers V., and Gartside S.E. Br. J. Pharmacol. 121 (1997) 941-946
18. Albert P.R., and Lemonde S. Neuroscientist 10 (2004) 575-593
19. Honorio K.M., Garratt R.C., Polikatpov I., and Andricopulo A.D. J. Mol. Graph. Model. 25 (2007) 921-927
20. Salum L.B., Polikarpov I., and Andricopulo A.D. J. Mol. Graph. Model. 26 (2007) 434-442
21. Cramer III R.D., Patterson D.E., and Bunce J.D. J. Am. Chem. Soc. 110 (1988) 5959-5967
22. Tropsha A. Application of predictive QSAR models to database mining. In: Oprea T. (Ed). Chemoinformatics in Drug Discovery (2005), Wiley-VCH, Weinheim
23. Richmond N.J., Abrams C.A., Wolohan P.R., Abrahamian E., Willett P., and Clark R.D. GALAHAD: 1. J. Comput. Aided. Mol. Des. 20 (2006) 567-587
24. Shepphird J.K., and Clark R.D. J. Comput. Aided Mol. Des 20 (2006) 763-771
25. Andrade C.H., Salum L.B., Pasqualoto K.F.M., Ferreira E.I., and Andricopulo A.D. Lett. Drug Des. Discov. 5 (2008) 377-387
26. Doweyko A.M. J. Comput. Aided Mol. Des 18 (2004) 587-596
27. Wolber G., Seidel T., Bendix F., and Langer T. Drug Discov. Today 13 (2008) 23-29
28. Hibert M.F., Gittos M.W., Middlemiss D.N., Mir A.K., and Fozard J.R. J. Med. Chem. 31 (1988) 1087-1093
29. Hibert M.F., McDermott I., Middlemiss D.N., Mir A.K., and Fozard J.R. Eur. J. Med. Chem. 24 (1989) 31-37
30. Guan X.M., Peroutka S.J., and Kobilka B.K. Mol. Pharmacol. 41 (1992) 695-698
31. López-Rodríguez M.L., Morcillo M.J., Fernández E., Benhamú B., Tejada I., Ayala D., Viso A., Campillo M., Pardo L., Delgado M., Manzanares J., and Fuentes J.A. J. Med. Chem. 48 (2005) 2548-2558
32. Dabrowska J., and Brylinski M. Biochem. Pharmacol. 72 (2006) 498-511
33. Zlatovic M.V., Sukalovic V.V., Schneiderc C., and Roglic G.M. Bioorg. Med. Chem. 14 (2006) 2994-3001
34. Clark R.D., and Foz P.C. J. Comput. Aided Mol. Des 18 (2004) 563-576
35. Andricopulo A.D., and Montanari C.A. Mini Rev. Med. Chem. 5 (2005) 585-593
36. Guido R.V.C., Oliva G., Montanari C.A., and Andricopulo A.D. J. Chem. Inf. Model. 48 (2008) 918-929
37. Guido R.V.C., Oliva G., and Andricopulo A.D. Curr. Med. Chem. 15 (2008) 37-46